186 related articles for article (PubMed ID: 28133938)
1. Characterization of hallucinogenic phenethylamines using high-resolution mass spectrometry for non-targeted screening purposes.
Pasin D; Cawley A; Bidny S; Fu S
Drug Test Anal; 2017 Oct; 9(10):1620-1629. PubMed ID: 28133938
[TBL] [Abstract][Full Text] [Related]
2. Retrospective Demonstration of 25I-NBOMe Acute Poisoning Using Hair Analysis.
Ameline A; Farrugia A; Raul JS; Kintz P
Curr Pharm Biotechnol; 2017; 18(10):786-790. PubMed ID: 29189143
[TBL] [Abstract][Full Text] [Related]
3. Analytical characterization of three hallucinogenic N-(2-methoxy)benzyl derivatives of the 2C-series of phenethylamine drugs.
Zuba D; Sekuła K
Drug Test Anal; 2013 Aug; 5(8):634-45. PubMed ID: 22936468
[TBL] [Abstract][Full Text] [Related]
4. Mass spectrometric properties of N-(2-methoxybenzyl)-2-(2,4,6-trimethoxyphenyl)ethanamine (2,4,6-TMPEA-NBOMe), a new representative of designer drugs of NBOMe series and derivatives thereof.
Shevyrin V; Kupriyanova O; Lebedev AT; Melkozerov V; Eltsov O; Shafran Y; Morzherin Y; Sadykova R
J Mass Spectrom; 2016 Oct; 51(10):969-979. PubMed ID: 27388323
[TBL] [Abstract][Full Text] [Related]
5. 25C-NBOMe and 25I-NBOMe metabolite studies in human hepatocytes, in vivo mouse and human urine with high-resolution mass spectrometry.
Wohlfarth A; Roman M; Andersson M; Kugelberg FC; Diao X; Carlier J; Eriksson C; Wu X; Konradsson P; Josefsson M; Huestis MA; Kronstrand R
Drug Test Anal; 2017 May; 9(5):680-698. PubMed ID: 27448631
[TBL] [Abstract][Full Text] [Related]
6. 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe): clinical case with unique confirmatory testing.
Stellpflug SJ; Kealey SE; Hegarty CB; Janis GC
J Med Toxicol; 2014 Mar; 10(1):45-50. PubMed ID: 23872917
[TBL] [Abstract][Full Text] [Related]
7. 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOME): A Harmful Hallucinogen Review.
Kamińska K; Świt P; Malek K
J Anal Toxicol; 2021 Jan; 44(9):947-956. PubMed ID: 32128596
[TBL] [Abstract][Full Text] [Related]
8. Analysis of 25I-NBOMe, 25B-NBOMe, 25C-NBOMe and Other Dimethoxyphenyl-N-[(2-Methoxyphenyl) Methyl]Ethanamine Derivatives on Blotter Paper.
Poklis JL; Raso SA; Alford KN; Poklis A; Peace MR
J Anal Toxicol; 2015 Oct; 39(8):617-23. PubMed ID: 26378135
[TBL] [Abstract][Full Text] [Related]
9. Multimodal imaging of hallucinogens 25C- and 25I-NBOMe on blotter papers.
Lützen E; Holtkamp M; Stamme I; Schmid R; Sperling M; Pütz M; Karst U
Drug Test Anal; 2020 Apr; 12(4):465-471. PubMed ID: 31846172
[TBL] [Abstract][Full Text] [Related]
10. 25I-NBOMe related death in Australia: a case report.
Kueppers VB; Cooke CT
Forensic Sci Int; 2015 Apr; 249():e15-8. PubMed ID: 25747271
[TBL] [Abstract][Full Text] [Related]
11. MS-Based Molecular Networking of Designer Drugs as an Approach for the Detection of Unknown Derivatives for Forensic and Doping Applications: A Case of NBOMe Derivatives.
Yu JS; Seo H; Kim GB; Hong J; Yoo HH
Anal Chem; 2019 May; 91(9):5483-5488. PubMed ID: 30990678
[TBL] [Abstract][Full Text] [Related]
12. Hallucinogen-Like Action of the Novel Designer Drug 25I-NBOMe and Its Effect on Cortical Neurotransmitters in Rats.
Herian M; Wojtas A; Kamińska K; Świt P; Wach A; Gołembiowska K
Neurotox Res; 2019 Jul; 36(1):91-100. PubMed ID: 30989482
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of 2,5-dimethoxy-3,4-dimethyl-β-phenethylamine (2C-G)--a new designer drug.
Zuba D; Sekuła K
Drug Test Anal; 2013 Jul; 5(7):549-59. PubMed ID: 22927304
[TBL] [Abstract][Full Text] [Related]
14. High-performance liquid chromatography tandem mass spectrometry method for the determination of 2CC-NBOMe and 25I-NBOMe in human serum.
Poklis JL; Charles J; Wolf CE; Poklis A
Biomed Chromatogr; 2013 Dec; 27(12):1794-800. PubMed ID: 23893863
[TBL] [Abstract][Full Text] [Related]
15. High-performance liquid chromatography with tandem mass spectrometry for the determination of nine hallucinogenic 25-NBOMe designer drugs in urine specimens.
Poklis JL; Clay DJ; Poklis A
J Anal Toxicol; 2014 Apr; 38(3):113-21. PubMed ID: 24535338
[TBL] [Abstract][Full Text] [Related]
16. Rapid Screening Method for New Psychoactive Substances of Forensic Interest: Electrochemistry and Analytical Determination of Phenethylamines Derivatives (NBOMe) via Cyclic and Differential Pulse Voltammetry.
Andrade AF; Mamo SK; Gonzalez-Rodriguez J
Anal Chem; 2017 Feb; 89(3):1445-1452. PubMed ID: 28059498
[TBL] [Abstract][Full Text] [Related]
17. Metabolic characterization of 25X-NBOH and 25X-NBOMe phenethylamines based on UHPLC-Q-Exactive Orbitrap MS in human liver microsomes.
Xiang J; Wen D; Zhai W; Zhao J; Xiang P; Ma C; Shi Y
J Pharm Biomed Anal; 2024 May; 242():116020. PubMed ID: 38359493
[TBL] [Abstract][Full Text] [Related]
18. The detection of NBOMe designer drugs on blotter paper by high resolution time-of-flight mass spectrometry (TOFMS) with and without chromatography.
Botch-Jones S; Foss J; Barajas D; Kero F; Young C; Weisenseel J
Forensic Sci Int; 2016 Oct; 267():89-95. PubMed ID: 27572638
[TBL] [Abstract][Full Text] [Related]
19. Identification of five substituted phenethylamine derivatives 5-MAPDB, 5-AEDB, MDMA methylene homolog, 6-Br-MDMA, and 5-APB-NBOMe.
Liu C; Jia W; Qian Z; Li T; Hua Z
Drug Test Anal; 2017 Feb; 9(2):199-207. PubMed ID: 26856255
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel psychoactive substances 25B-NBOMe and 4-CMC in biological material using HPLC-Q-TOF-MS and their quantification in blood using UPLC-MS/MS in case of severe intoxications.
Wiergowski M; Aszyk J; Kaliszan M; Wilczewska K; Anand JS; Kot-Wasik A; Jankowski Z
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jan; 1041-1042():1-10. PubMed ID: 27992785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
